Trial of Chidamide in Combination With Exemestane in Patients With Advanced Breast Cancer
Clinical trial NCT02482753 · COMPLETED
Trial details
- NCT number
- NCT02482753
- Sponsor
- Chipscreen Biosciences, Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-07-01
- Primary completion
- 2018-03-01
- Enrollment
- 365
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.